与转移性宫癌的tisotumab vedotin-tftv相关的急性角膜结膜炎

Ankur A Parikh1, Jovana Hanna2, Amar P Shah1,3

  • 1Department of Ophthalmology, University of Cincinnati College of Medicine, Cincinnati, OH, USA.

概括

抗体-药物结合物tisotumab vedotin-tftv在宫癌患者中引起了长期的眼球表面疾病,导致治疗中止. 眼科医生必须对新出现的抗体-药物合物进行这些不良反应的监测.